{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:19:49Z","timestamp":1773065989985,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1AI027762"],"award-info":[{"award-number":["RO1AI027762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.virol.2018.03.023","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T19:04:14Z","timestamp":1522782254000},"page":"398-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Inhibition of vaccinia virus replication by nitazoxanide"],"prefix":"10.1016","volume":"518","author":[{"given":"Sarah E.","family":"Hickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daciana","family":"Margineantu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Hockenbery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian A.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam P.","family":"Geballe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2018.03.023_bib1","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M117.791863","article-title":"The unintended mitochondrial uncoupling effects of the FDA approved anti-helminth drug nitazoxanide mitigates experimental Parkinsonism in mice","author":"Amireddy","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.03.023_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.virol.2014.05.015","article-title":"Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca(2+) stores","volume":"462\u2013463","author":"Ashiru","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.03.023_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.toxlet.2011.03.013","article-title":"Linking energy metabolism to dysfunctions in mitochondrial respiration--a metabolomics in vitro approach","volume":"203","author":"Balcke","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.virol.2018.03.023_bib4","first-page":"43","article-title":"Bioavailability of two oral-suspension formulations of a single dose of nitazoxanide 500 mg: an open-label, randomized-sequence, two-period crossover, comparison in healthy fasted Mexican adult volunteers","volume":"3","author":"Balderas-Acata","year":"2011","journal-title":"Bioequivalence Bioavailab."},{"key":"10.1016\/j.virol.2018.03.023_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/jvi.69.1.499-505.1995","article-title":"Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene","volume":"69","author":"Beattie","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1086\/374244","article-title":"Progressive vaccinia","volume":"36","author":"Bray","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2018.03.023_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.chom.2015.02.003","article-title":"Cellular 5\u2032\u22123\u2032 mRNA exonuclease Xrn1 controls double-stranded RNA accumulation and anti-viral responses","volume":"17","author":"Burgess","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2018.03.023_bib8","doi-asserted-by":"crossref","first-page":"e1005966","DOI":"10.1371\/journal.ppat.1005966","article-title":"A single amino acid dictates protein kinase R susceptibility to unrelated viral antagonists","volume":"12","author":"Carpentier","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.03.023_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-virology-031413-085442","article-title":"Oncolytic poxviruses","volume":"1","author":"Chan","year":"2014","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13238-012-2063-0","article-title":"The essential adaptors of innate immune signaling","volume":"4","author":"Chen","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.virol.2018.03.023_bib11","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1128\/JVI.06158-11","article-title":"Species specificity of protein kinase r antagonism by cytomegalovirus TRS1 genes","volume":"86","author":"Child","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/JVI.78.1.197-205.2004","article-title":"Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1","volume":"78","author":"Child","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib13","doi-asserted-by":"crossref","first-page":"10173","DOI":"10.1128\/JVI.00905-06","article-title":"Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins","volume":"80","author":"Child","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib14","first-page":"92","article-title":"Antagonism of the protein kinase R pathway in human cells by rhesus cytomegalovirus","author":"Child","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib15","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1128\/JVI.76.10.4912-4918.2002","article-title":"Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus","volume":"76","author":"Child","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib16","unstructured":"clinicaltrials.gov. U.S. National Library of Medicine. (Date accessed: 29 November 2017)."},{"key":"10.1016\/j.virol.2018.03.023_bib17","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1128\/JVI.00169-10","article-title":"Activation of the interferon response by human cytomegalovirus occurs via cytoplasmic double-stranded DNA but not glycoprotein B","volume":"84","author":"DeFilippis","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib18","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1053\/j.gastro.2009.07.056","article-title":"The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation","volume":"137","author":"Elazar","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2018.03.023_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature02007","article-title":"Planning for smallpox outbreaks","volume":"425","author":"Ferguson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.03.023_bib20","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1128\/JVI.03134-13","article-title":"Vaccinia virus requires glutamine but not glucose for efficient replication","volume":"88","author":"Fontaine","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.immuni.2016.06.015","article-title":"The AIM2-like receptors are dispensable for the interferon response to intracellular DNA","volume":"45","author":"Gray","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2018.03.023_bib22","doi-asserted-by":"crossref","first-page":"e1004021","DOI":"10.1371\/journal.ppat.1004021","article-title":"De novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infection","volume":"10","author":"Greseth","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.03.023_bib23","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1128\/JVI.02526-12","article-title":"Hepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthase","volume":"87","author":"Huang","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib24","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1128\/AAC.00670-16","article-title":"Synthesis and antimicrobial evaluation of amixicile-based inhibitors of the pyruvate-ferredoxin oxidoreductases of anaerobic bacteria and epsilonproteobacteria","volume":"60","author":"Kennedy","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2018.03.023_bib25","doi-asserted-by":"crossref","DOI":"10.1089\/hs.2017.0061","article-title":"The de novo synthesis of horsepox virus: implications for biosecurity and recommendations for preventing the reemergence of smallpox","author":"Koblentz","year":"2017","journal-title":"Health Secur."},{"key":"10.1016\/j.virol.2018.03.023_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2007.08.005","article-title":"Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication","volume":"77","author":"Korba","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2018.03.023_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/irv.12446","article-title":"Influenza antivirals currently in late-phase clinical trial","volume":"11","author":"Koszalka","year":"2017","journal-title":"Influenza Other Respir. Virus."},{"key":"10.1016\/j.virol.2018.03.023_bib28","doi-asserted-by":"crossref","first-page":"e1002691","DOI":"10.1371\/journal.ppat.1002691","article-title":"Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis","volume":"8","author":"Lam","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.03.023_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/viro.2002.1479","article-title":"The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range","volume":"299","author":"Langland","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.03.023_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.actatropica.2015.04.019","article-title":"Combined flubendazole-nitazoxanide treatment of cystic echinococcosis: pharmacokinetic and efficacy assessment in mice","volume":"148","author":"Laura","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.virol.2018.03.023_bib31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ijc.30074","article-title":"Mitochondrial DNA sensing by STING signaling participates in inflammation, cancer and beyond","volume":"139","author":"Liu","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virol.2018.03.023_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/JVI.02426-13","article-title":"The D10 decapping enzyme of vaccinia virus contributes to decay of cellular and viral mRNAs and to virulence in mice","volume":"88","author":"Liu","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta\u00a0C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.virol.2018.03.023_bib34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2018.03.023_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.virol.2010.10.019","article-title":"Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus","volume":"409","author":"Meng","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.03.023_bib36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.chembiol.2015.12.012","article-title":"Drug repurposing approach identifies inhibitors of the prototypic viral transcription factor IE2 that block human cytomegalovirus replication","volume":"23","author":"Mercorelli","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.virol.2018.03.023_bib37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.chembiol.2013.03.014","article-title":"Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication","volume":"20","author":"Nasheri","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.virol.2018.03.023_bib38","first-page":"CD009182","article-title":"Nitazoxanide for chronic hepatitis C","author":"Nikolova","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.virol.2018.03.023_bib39","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1099\/vir.0.83491-0","article-title":"Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2","volume":"89","author":"Oem","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib40","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1074\/jbc.M808773200","article-title":"Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway","volume":"284","author":"Park","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.03.023_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/JVI.80.2.553-561.2006","article-title":"Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression","volume":"80","author":"Parrish","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.15585\/mmwr.mm6510a2","article-title":"Use of vaccinia virus smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to orthopoxviruses - recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015","volume":"65","author":"Petersen","year":"2016","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.virol.2018.03.023_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1089\/aid.2015.0236","article-title":"Interferon stimulated gene expression in HIV\/HCV coinfected patients treated with nitazoxanide\/peginterferon-alfa-2a and ribavirin","volume":"32","author":"Petersen","year":"2016","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.virol.2018.03.023_bib44","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.cell.2014.11.037","article-title":"Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA","volume":"159","author":"Rongvaux","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.virol.2018.03.023_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2018.03.023_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/17460913.3.5.539","article-title":"Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C","volume":"3","author":"Rossignol","year":"2008","journal-title":"Fut. Microbiol."},{"key":"10.1016\/j.virol.2018.03.023_bib47","doi-asserted-by":"crossref","first-page":"29798","DOI":"10.1074\/jbc.M109.029470","article-title":"Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level","volume":"284","author":"Rossignol","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.03.023_bib48","article-title":"Update on nitazoxanide: a multifunctional chemotherapeutic agent","author":"Shakya","year":"2017","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.virol.2018.03.023_bib49","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.73.1.791-796.1999","article-title":"Down regulation of gene expression by the vaccinia virus D10 protein","volume":"73","author":"Shors","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib50","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1128\/JVI.02630-10","article-title":"Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication","volume":"85","author":"Spencer","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.023_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5414\/CPP40213","article-title":"Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses","volume":"40","author":"Stockis","year":"2002","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.virol.2018.03.023_bib52","first-page":"349","article-title":"Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers","volume":"34","author":"Stockis","year":"1996","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.virol.2018.03.023_bib53","doi-asserted-by":"crossref","first-page":"27148","DOI":"10.1038\/srep27148","article-title":"Thiazolides elicit anti-viral innate immunity and reduce HIV replication","volume":"6","author":"Trabattoni","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2018.03.023_bib54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrm3305","article-title":"A two-way street: reciprocal regulation of metabolism and signalling","volume":"13","author":"Wellen","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.virol.2018.03.023_bib55","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.22508","article-title":"Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production","volume":"48","author":"Yang","year":"2008","journal-title":"Hepatology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218301028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218301028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:50:15Z","timestamp":1758588615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682218301028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":55,"alternative-id":["S0042682218301028"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2018.03.023","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of vaccinia virus replication by nitazoxanide","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2018.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}